5398712025-01-012025-03-315398712025-03-315398712025-01-012025-03-31CompositionOfBoardOfDirectors15398712025-03-31CompositionOfBoardOfDirectors15398712025-01-012025-03-31CompositionOfBoardOfDirectors25398712025-03-31CompositionOfBoardOfDirectors25398712025-01-012025-03-31CompositionOfBoardOfDirectors35398712025-03-31CompositionOfBoardOfDirectors35398712025-01-012025-03-31CompositionOfBoardOfDirectors45398712025-03-31CompositionOfBoardOfDirectors45398712025-01-012025-03-31CompositionOfBoardOfDirectors55398712025-03-31CompositionOfBoardOfDirectors55398712025-01-012025-03-31CompositionOfBoardOfDirectors65398712025-03-31CompositionOfBoardOfDirectors65398712025-01-012025-03-31CompositionOfBoardOfDirectors75398712025-03-31CompositionOfBoardOfDirectors75398712025-01-012025-03-31CompositionOfBoardOfDirectors85398712025-03-31CompositionOfBoardOfDirectors85398712025-01-012025-03-31CompositionOfBoardOfDirectors95398712025-03-31CompositionOfBoardOfDirectors95398712025-01-012025-03-31CompositionOfCommittees145398712025-03-31CompositionOfCommittees145398712025-01-012025-03-31CompositionOfCommittees155398712025-03-31CompositionOfCommittees155398712025-01-012025-03-31CompositionOfCommittees165398712025-03-31CompositionOfCommittees165398712025-01-012025-03-31CompositionOfCommittees175398712025-03-31CompositionOfCommittees175398712025-01-012025-03-31CompositionOfCommittees415398712025-03-31CompositionOfCommittees415398712025-01-012025-03-31CompositionOfCommittees425398712025-03-31CompositionOfCommittees425398712025-01-012025-03-31CompositionOfCommittees435398712025-03-31CompositionOfCommittees435398712025-01-012025-03-31CompositionOfCommittees685398712025-03-31CompositionOfCommittees685398712025-01-012025-03-31CompositionOfCommittees695398712025-03-31CompositionOfCommittees695398712025-01-012025-03-31CompositionOfCommittees705398712025-03-31CompositionOfCommittees705398712025-01-012025-03-31CompositionOfCommittees955398712025-03-31CompositionOfCommittees955398712025-01-012025-03-31CompositionOfCommittees965398712025-03-31CompositionOfCommittees965398712025-01-012025-03-31CompositionOfCommittees975398712025-03-31CompositionOfCommittees975398712025-01-012025-03-31CompositionOfCommittees985398712025-03-31CompositionOfCommittees985398712025-01-012025-03-31CompositionOfCommittees1225398712025-03-31CompositionOfCommittees1225398712025-01-012025-03-31CompositionOfCommittees1235398712025-03-31CompositionOfCommittees1235398712025-01-012025-03-31CompositionOfCommittees1245398712025-03-31CompositionOfCommittees1245398712025-03-31MeetingOfBoardOfDirectors15398712025-01-012025-03-31MeetingOfBoardOfDirectors15398712025-03-31MeetingOfBoardOfDirectors25398712025-01-012025-03-31MeetingOfBoardOfDirectors25398712025-01-012025-03-31MeetingOfCommittees15398712025-03-31MeetingOfCommittees15398712025-01-012025-03-31MeetingOfCommittees25398712025-03-31MeetingOfCommittees25398712025-01-012025-03-31MeetingOfCommittees35398712025-03-31MeetingOfCommittees35398712025-01-012025-03-31MeetingOfCommittees45398712025-03-31MeetingOfCommittees45398712025-01-012025-03-31MeetingOfCommittees55398712025-03-31MeetingOfCommittees55398712024-12-315398712025-03-31ImpositionOfFineOrPenaltyDomain15398712025-03-31ImpositionOfFineOrPenaltyDomain25398712025-03-31ImpositionOfFineOrPenaltyDomain35398712025-03-31OngoingTaxLitigationsOrDisputesDomain15398712025-03-31OngoingTaxLitigationsOrDisputesDomain2xbrli:pure539871THYROCARENOTLISTEDINE594H01019Thyrocare Technologies Limited2024-04-012025-03-31Yearly2025-03-31EquitytruetruefalseThere were no transactions involving acquisition of Shares or Voting Rights which are required to be reported as per terms of sub-para 1 of Para A of Part A of Schedule III of SEBI LODR 2015, for the Quarter ended March 31, 2025. During the period January to March 2025, the Company has made an additional equity investment of USD 25,000 on March 03, 2025, in its existing Joint Venture Company i.e. Thyrocare Laboratories (Tanzania) Limited (JV Company), towards subscription of additional shares in JV Company. The requisite disclosures were filed with the Stock Exchanges vide letter dated March 03, 2025.truetruefalseThe Company has not given any loans/ guarantees /comfort letters / securities directly or indirectly to Promoter/Promoter Group or any other entity controlled by promoter or Promoter group or Directors (including relatives) or any other entity controlled by them or KMPs or any other entity controlled by them.trueTop 1000 listed entitiestruet00551OriginaltruetrueMrRahul Guha09588432Executive DirectorChairpersonCEO-MD1978-03-02falseActiveNA2022-05-041020MrDharmil Nirupam ShethBMNPS9924H06999772Non-Executive - Non Independent DirectorNot Applicable1988-09-19falseActiveNA2021-09-021010MrHardik Kishor Dedhia06660799Non-Executive - Non Independent DirectorNot Applicable1989-02-17falseActiveNA2021-09-021010MrDhaval Rajesh ShahBQCPS5912E07485688Non-Executive - Non Independent DirectorNot Applicable1988-10-18falseActiveNA2021-10-061010MrsIndumati Gopinathan06779331Non-Executive - Independent DirectorNot Applicable1956-03-23falseActiveNA2017-08-122024-03-0972.211100MrsPrapti Ishwar GiladaANGPG8714N07125024Non-Executive - Independent DirectorNot Applicable1989-12-07falseActiveNA2023-07-142023-07-1420.161131MrHarshil Jiten Vora10232581Non-Executive - Independent DirectorNot Applicable1988-02-03falseActiveNA2023-07-142023-07-1420.161100MrAnandh SundarBUUPS7480P10409065Non-Executive - Independent DirectorNot Applicable1988-05-11falseActiveNA2024-06-152024-06-159.152231MrNishant Shah09025935Non-Executive - Independent DirectorNot Applicable1976-10-26falseActiveNA2024-06-152024-06-159.151122truetruetruetruetrueAudit Committee09025935Nishant ShahNon-Executive - Independent DirectorChairperson2024-06-15Audit Committee10409065Anandh SundarNon-Executive - Independent DirectorMember2024-06-15Audit Committee07125024Prapti Ishwar GiladaNon-Executive - Independent DirectorMember2023-07-14Audit Committee09588432Rahul GuhaExecutive DirectorMember2022-08-01Nomination and remuneration committee07125024Prapti Ishwar GiladaNon-Executive - Independent DirectorChairperson2023-10-31Nomination and remuneration committee06779331Indumati GopinathanNon-Executive - Independent DirectorMember2017-08-12Nomination and remuneration committee06999772Dharmil Nirupam ShethNon-Executive - Non Independent DirectorMember2023-07-14Stakeholders Relationship Committee07125024Prapti Ishwar GiladaNon-Executive - Independent DirectorChairperson2023-07-14Stakeholders Relationship Committee06999772Dharmil Nirupam ShethNon-Executive - Non Independent DirectorMember2021-09-02Stakeholders Relationship Committee06660799Hardik Kishor DedhiaNon-Executive - Non Independent DirectorMember2021-09-02Risk Management Committee07125024Prapti Ishwar GiladaNon-Executive - Independent DirectorChairperson2023-07-14Risk Management Committee06999772Dharmil Nirupam ShethNon-Executive - Non Independent DirectorMember2021-09-02Risk Management Committee06660799Hardik Kishor DedhiaNon-Executive - Non Independent DirectorMember2021-09-02Risk Management Committee09588432Rahul GuhaExecutive DirectorMember2022-08-01Corporate Social Responsibility Committee06779331Indumati GopinathanNon-Executive - Independent DirectorChairperson2023-07-14Corporate Social Responsibility Committee06660799Hardik Kishor DedhiaNon-Executive - Non Independent DirectorMember2021-09-02Corporate Social Responsibility Committee07485688Dhaval Rajesh ShahNon-Executive - Non Independent DirectorMember2023-10-312024-10-23true9952025-01-2391true985Audit Committee2024-10-23true4430Audit Committee2025-01-2391true4430Nomination and remuneration committee2024-10-23true3320Nomination and remuneration committee2025-01-2391true3320Corporate Social Responsibility Committee2025-01-23true3210truetruetruetrueYestruetruetrueBrijesh KumarCompany Secretary and Compliance OfficerYeshttps://www.thyrocare.com/Yeshttps://investor.thyrocare.com/wp-content/uploads/2025/03/MOA_AOA.pdfYeshttps://investor.thyrocare.com/board-of-directors/Yeshttps://investor.thyrocare.com/policies-codes/Yeshttps://investor.thyrocare.com/corporate-governance/composition-of-committee/Yeshttps://investor.thyrocare.com/policies-codes/Yeshttps://investor.thyrocare.com/policies-codes/Yeshttps://investor.thyrocare.com/policies-codes/Yeshttps://investor.thyrocare.com/policies-codes/Yeshttps://investor.thyrocare.com/policies-codes/Yeshttps://investor.thyrocare.com/policies-codes/Yeshttps://investor.thyrocare.com/investor-contacts/Yeshttps://investor.thyrocare.com/investor-contacts/Yeshttps://investor.thyrocare.com/financials/Yeshttps://investor.thyrocare.com/investors-information/NAYeshttps://investor.thyrocare.com/financials/quarterly-financial-results/Yeshttps://investor.thyrocare.com/financials/quarterly-financial-results/NAYeshttps://investor.thyrocare.com/news-paper-publications/NAYeshttps://investor.thyrocare.com/financials/subsidiary-financials/Yeshttps://investor.thyrocare.com/corporate-governance/secretarial-compliance-report/Yeshttps://investor.thyrocare.com/policies-codes/Yeshttps://investor.thyrocare.com/investor-contacts/Yeshttps://investor.thyrocare.com/announcements/NAYeshttps://investor.thyrocare.com/policies-codes/Yeshttps://investor.thyrocare.com/financials/annual-returns/Yeshttps://investor.thyrocare.com/wp-content/uploads/2025/03/Revised_TTL_ESOP-Scheme.pdfYeshttps://investor.thyrocare.com/Yeshttps://investor.thyrocare.com/YesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesNANAYesYesYesYesYesYesYesYesYesNANABrijesh KumarCompany Secretary and Compliance OfficerYesBrijesh KumarCompany Secretary and Compliance OfficerfalseBrijesh KumarCompany Secretary and Compliance OfficerNavi Mumbai2025-04-1500000Joint Commissioner of Income TaxPenalty of Rs. 5,89,625/- was levied on the Company vide order passed under section 271C of the Income Tax Act, 19612025-03-27Penalty proceedings under section 271C of the Act, regarding non-deduction and non deposition of TDS amount. (FY 2016-17)The financial impact of the Order is to the extent of the penalty levied. There is no impact on operations or other activities of the Company.Joint Commissioner of Income TaxPenalty of Rs. 2,36,902/- was levied on the Company vide order passed under section 271C of the Income Tax Act, 19612025-03-27Penalty proceedings under section 271C of the Act, regarding non-deduction and non deposition of TDS amount. (FY 2018-19)The financial impact of the Order is to the extent of the penalty levied. There is no impact on operations or other activities of the Company.Joint Commissioner of Income TaxPenalty of Rs 714/- was levied on the Company vide Order passed under section 271C of the Income Tax Act, 19612025-03-27Penalty proceedings under section 271C of the Act, regarding non-deduction and non deposition of TDS amount. (FY 2019-20)The financial impact of the Order is to the extent of the penalty levied. There is no impact on operations or other activities of the Company.Assessment Unit, Income Tax Department2024-07-18There is an ongoing assessment for the said year. The AO has asked various details and the submission has been done.Department has passed an order u/s 143(3) dated 17 March 2025 disallowancing sales incentive. The Company has filed an appeal in response of the same with CIT(A) relating to FY 2020-21.Deputy Commissioner of State Tax2025-01-06NAThe Company has filed reply to Notice ASMT-10 regarding alleged Excess ITC Availment for FY 2022-23.